Wordt geladen...
SUN-514 Severe Hypophosphatemia and Worsening Secondary Hyperparathyroidism Following Treatment with Denosumab
Introduction We present a case of a patient with osteoporosis and chronic kidney disease (CKD)-induced secondary hyperparathyroidism who developed severe hypophosphatemia and increasing parathyroid hormone (PTH) level after receiving Denosumab. Clinical Case 90-year-old male with CKD stage 3 present...
Bewaard in:
| Gepubliceerd in: | J Endocr Soc |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Endocrine Society
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553052/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-514 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|